Kestra Medical Technologies Reports Fiscal Quarter Results Ended July 31, 2026

What Happened
Kestra Medical Technologies, Ltd. announced its financial results for the fiscal quarter ended July 31, 2026 via a press release dated September 14, 2026. The company filed an Item 2.02 Form 8-K to furnish that press release (Exhibit 99.1), which the filing states is incorporated by reference. The Form 8-K was signed by Brian Webster, President and Chief Executive Officer.

Key Details

• Filing date: September 14, 2026 (Form 8-K filed under Item 2.02).
• Period covered: fiscal quarter ended July 31, 2026.
• Exhibit: Press release furnished as Exhibit 99.1 (also referenced in Item 9.01 alongside an Inline XBRL cover page, Exhibit 104).
• Authorized signatory: Brian Webster, President and CEO.

Why It Matters
This 8-K notifies investors that Kestra has publicly released its quarterly financial results; the short Form 8-K itself does not disclose the numeric results, so investors should review the furnished press release (Exhibit 99.1) or the company’s earnings materials for revenue, profit/loss, EPS, and any management commentary or guidance. Timely review of the full press release is important because quarterly results and management commentary can affect stock price and investor decisions.